Apr 26, 2017 11:01 am UTC| Business
BOSTON, April 26, 2017 -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry, announced...
Universal Stainless Reports First Quarter 2017 Results
Apr 26, 2017 11:01 am UTC| Business
Sales in Q1 Total $48.9 Million, Up 43.1% Sequentially, and Up 23.4% vs. Q1 2016Net Loss in Q1 Totals $0.17 per Diluted Share and Includes $0.06 Loss for Non-Recurring ItemsEBITDA in Q1 Totals $4.2 Million, Up 31.9%...
Insmed to Host First Quarter 2017 Financial Results Conference Call on Wednesday, May 3, 2017
Apr 26, 2017 11:01 am UTC| Business
BRIDGEWATER, N.J., April 26, 2017 -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that it will release its first...
Insmed to Host First Quarter 2017 Financial Results Conference Call on Wednesday, May 3, 2017
Apr 26, 2017 11:01 am UTC| Business
BRIDGEWATER, N.J., April 26, 2017 -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that it will release its first...
PRGX Global, Inc. Announces First Quarter 2017 Financial Results
Apr 26, 2017 11:01 am UTC| Business
ATLANTA, April 26, 2017 -- PRGX Global, Inc. (Nasdaq:PRGX), a global leader in Recovery Audit and Spend Analytics services, today announced its unaudited financial results for the first quarter ended March 31, 2017. ...
PRGX Global, Inc. Announces First Quarter 2017 Financial Results
Apr 26, 2017 11:01 am UTC| Business
ATLANTA, April 26, 2017 -- PRGX Global, Inc. (Nasdaq:PRGX), a global leader in Recovery Audit and Spend Analytics services, today announced its unaudited financial results for the first quarter ended March 31, 2017. ...
miRagen Therapeutics to Participate in Two Investor Conferences in May
Apr 26, 2017 11:01 am UTC| Business
BOULDER, Colo., April 26, 2017 -- Miragen Therapeutics, Inc. (Nasdaq:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of microRNA-targeted therapies, today announced that...